Search
Search Funnelback University
1 -
13 of
13
search results for `p53 tumour suppressor` |u:www2.mrc-lmb.cam.ac.uk
Fully-matching results
-
Alan Fersht - MRC Laboratory of Molecular Biology
https://www2.mrc-lmb.cam.ac.uk/group-leaders/emeritus/alan-fersht/21 Jul 2023: Alan Fersht. Tumour suppressor p53 structure and drug discovery. Alan Fersht was a Natural Sciences undergraduate and Chemistry postgraduate at Gonville and Caius from 1962-68. ... Cancer is a disease of mutation, and the most commonly mutated protein by -
Protein and Nucleic Acid Chemistry - MRC Laboratory of Molecular…
https://www2.mrc-lmb.cam.ac.uk/research/protein-and-nucleic-acid-chemistry/20 May 2024: Alan Fersht - Tumour suppressor p53 structure and drug discovery. -
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/pages/61
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/pages/61{"id":61,"date":"2012-06-25T10:03:42","date_gmt":"2012-06-25T10:03:42","guid":{"rendered":"http://www2.mrc-lmb.cam.ac.uk/wordpress/?page_id=61"},"modified":"2024-05-20T14:39:16","modified_gmt":"2024-05-20T13:39:16","slug":"protein-and-nucleic-acid-ch -
index.html
https://www2.mrc-lmb.cam.ac.uk/groups/fersht/26 Jan 2021: Cancer is a disease of mutation, and the most commonly mutated protein by far is the tumour suppressor p53. ... Tumour Suppressor p53. Structural Biology and Drug Discovery. Alan Fersht. MRC Laboratory of Molecular Biology. -
Emeritus - MRC Laboratory of Molecular Biology
https://www2.mrc-lmb.cam.ac.uk/group-leaders/emeritus/21 Jul 2023: Tumour suppressor p53 structure and drug discovery. LMB Division - Protein and Nucleic Acid Chemistry. -
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/pages/117
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/pages/117Alan rejoined the LMB in 2010, where he continued his work on protein folding, misfolding and disease, concentrating on the tumour suppressor p53 until the end of 2017. ... n. Cancer is a disease of mutation, and the most commonly mutated protein by far -
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/11070
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/11070can bind to and deactivate an enzyme that controls the stability of the p53 tumour suppressor protein. ... This deactivation allows p53 to be turned on, putting the brakes on cancer growth. -
Researchers "drug the undruggable" - MRC Laboratory of…
https://www2.mrc-lmb.cam.ac.uk/researchers-drug-undruggable/20 Oct 2017: can bind to and deactivate an enzyme that controls the stability of the p53 tumour suppressor protein. ... This deactivation allows p53 to be turned on, putting the brakes on cancer growth. -
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/3293
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/3293nAlan will continue to lead his research on the p53 tumour suppressor protein at the LMB with an MRC programme grant for the next five years. -
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/18741
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/18741{"id":18741,"date":"2020-08-04T17:10:07","date_gmt":"2020-08-04T16:10:07","guid":{"rendered":"https://www2.mrc-lmb.cam.ac.uk/?p=18741"},"modified":"2020-08-04T17:10:09","modified_gmt":"2020-08-04T16:10:09","slug":"alan-fersht-and-marta-zlatic-win-roy -
LMB continues pioneering work started in CPE - MRC Laboratory of…
https://www2.mrc-lmb.cam.ac.uk/lmb-continues-pioneering-work-started-in-cpe/24 Sep 2010: Alan will continue to lead his research on the p53 tumour suppressor protein at the LMB with an MRC programme grant for the next five years. -
LMB Scientists Awarded Prestigious European Grants - MRC Laboratory…
https://www2.mrc-lmb.cam.ac.uk/lmb-scientists-awarded-prestigious-european-grants/26 Nov 2010: Professor Sir Alan Fersht, FRS, from the PNAC Division of LMB, has been awarded an Advanced ERC Grant of 1.5m for his project “Tumour suppressor p53: structure, stability and novel ... Alan’s grant complements his MRC programme grant on the -
Alan Fersht and Marta Zlatic win Royal Society Medals - MRC…
https://www2.mrc-lmb.cam.ac.uk/alan-fersht-and-marta-zlatic-win-royal-society-medals/4 Aug 2020: Alan’s most recent interest is in the tumour suppressor p53, with the aim to understand how mutations affect its function, so that novel anti-cancer drugs may be designed to
Refine your results
Date
- 5 Uncertain
- 2 2023
- 2 2010
- 1 Past 3 months
- 1 2017
- 1 Past 6 months
- 1 2024
- 1 Past year
- 1 2021
- 1 2020
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.